Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Lakshmi Nayak"'
Autor:
Vishal Raval, Elaine Binkley, Mary E. Aronow, Juan Valenzuela, David M. Peereboom, Wei Wei, Sunil Srivastava, Jaqueline Davanzo, Herbert Culver Boldt, Mark P. McGarrey, George N. Papaliodis, Lucia Sobrin, Ivana K. Kim, Dimitrios G. Vavvas, Dean Eliott, Lakshmi Nayak, Emilio Dodds, Francisco Marco del Pont, Arun D. Singh
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 362-370 (2022)
Abstract There is limited understanding of the inter‐compartmental progression and treatment outcomes of primary central nervous system lymphoma (PCNSL). In this multicenter retrospective cohort study on 234 patients with PCNSL (median age: 62.5 ye
Externí odkaz:
https://doaj.org/article/be506312b9b24579ace478741d438474
Autor:
Eudocia Q. Lee, Alona Muzikansky, Dan G. Duda, Sarah Gaffey, Jorg Dietrich, Lakshmi Nayak, Ugonma N. Chukwueke, Rameen Beroukhim, Lisa Doherty, Caroline Kane Laub, Debra LaFrankie, Brittney Fontana, Jennifer Stefanik, Sandra Ruland, Victoria Caruso, Jennifer Bruno, Keith Ligon, David A. Reardon, Patrick Y. Wen
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5988-5994 (2019)
Abstract Background Responses to bevacizumab in glioblastoma (GBM) are not durable. Plasma levels of basic fibroblast growth factor (bFGF) increase at the time of tumor progression. By targeting vascular endothelial growth factor receptor (VEGFR), pl
Externí odkaz:
https://doaj.org/article/57064c00cd29451f907052cc6b3f6e14
Alternative Diagnostic Strategy for the Assessment and Treatment of Pulmonary Embolus: A Case Series
Autor:
Ayaz Aghayev, Aliza A. Memon, Paul Gregg Greenough, Lakshmi Nayak, Sijie Zheng, Andrew M. Siedlecki
Publikováno v:
Clinical Practice and Cases in Emergency Medicine, Vol 4, Iss 3 (2020)
Introduction: Ferumoxytol-enhanced magnetic resonance angiography (FeMRA) can be used as an alternate and safe method to diagnose patients with compromised renal function who present with acute pulmonary embolus in the emergency department (ED) setti
Externí odkaz:
https://doaj.org/article/9a4ce87bdd2f4dd3903525da5f4038fc
Autor:
Lakshmi Nayak, Claire Henchcliffe
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 1, Pp 11-20 (2008)
Lakshmi Nayak1, Claire Henchcliffe21Department of Neurology; 2Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, USAAbstract: Rasagiline (N-propargyl-1 (R)-aminoindan) is a novel propargylamine, irreversi
Externí odkaz:
https://doaj.org/article/2700160b77974365b071192318f7b89c
Autor:
David A. Reardon, Patrick Y. Wen, Rakesh K. Jain, Alona Muzikansky, Dan G. Duda, Wendy M. Blumenschein, Qing Zhao, Jennifer H. Yearley, Mariano Severgnini, David J. Cote, Timothy R. Smith, Sarah Gaffey, Christine McCluskey, Howard Colman, Thomas Kaley, Leia Nghiemphu, John de Groot, Justin T. Jordan, Jennifer L. Clarke, Katherine Peters, Annette M. Molinaro, Lakshmi Nayak
Study data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3687ad6fd7f25a5651346719938c7686
https://doi.org/10.1158/1078-0432.22479269.v1
https://doi.org/10.1158/1078-0432.22479269.v1
Autor:
David A. Reardon, Patrick Y. Wen, Rakesh K. Jain, Alona Muzikansky, Dan G. Duda, Wendy M. Blumenschein, Qing Zhao, Jennifer H. Yearley, Mariano Severgnini, David J. Cote, Timothy R. Smith, Sarah Gaffey, Christine McCluskey, Howard Colman, Thomas Kaley, Leia Nghiemphu, John de Groot, Justin T. Jordan, Jennifer L. Clarke, Katherine Peters, Annette M. Molinaro, Lakshmi Nayak
Purpose:VEGF is upregulated in glioblastoma and may contribute to immunosuppression. We performed a phase II study of pembrolizumab alone or with bevacizumab in recurrent glioblastoma.Patients and Methods:Eighty bevacizumab-naïve patients with recur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cf17076b54f819b7cca2dec022f7f49
https://doi.org/10.1158/1078-0432.c.6530168
https://doi.org/10.1158/1078-0432.c.6530168
Autor:
David A. Reardon, Patrick Y. Wen, Rakesh K. Jain, Alona Muzikansky, Dan G. Duda, Wendy M. Blumenschein, Qing Zhao, Jennifer H. Yearley, Mariano Severgnini, David J. Cote, Timothy R. Smith, Sarah Gaffey, Christine McCluskey, Howard Colman, Thomas Kaley, Leia Nghiemphu, John de Groot, Justin T. Jordan, Jennifer L. Clarke, Katherine Peters, Annette M. Molinaro, Lakshmi Nayak
Data table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b53b513097052bfa25f7f0b92423414
https://doi.org/10.1158/1078-0432.22479266.v1
https://doi.org/10.1158/1078-0432.22479266.v1
Autor:
David A. Reardon, Thomas Kaley, Raymond Y. Huang, Todd Creasy, Nicholas M. Durham, Melissa de los Reyes, Ralph Venhaus, Paul Schwarzenberger, Aileen Ryan, Toni Ricciardi, Andrew J. Park, Mary Macri, Patrick Y. Wen, Christina Holcroft, Julia Hayden, Sarah Gaffey, Elizabeth George, Elizabeth Flagg, Hui K. Gan, Timothy Cloughesy, Michael Lim, Gavin P. Dunn, Jennifer L. Clarke, Jorg Dietrich, Nathan Standifer, Lakshmi Nayak
Purpose:PD-L1 is upregulated in glioblastoma and supports immunosuppression. We evaluated PD-L1 blockade with durvalumab among glioblastoma cohorts and investigated potential biomarkers.Patients and Methods:MGMT unmethylated newly diagnosed patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7efa7d78afec58d9243a7359a5ad51
https://doi.org/10.1158/1078-0432.c.6532395.v1
https://doi.org/10.1158/1078-0432.c.6532395.v1
Autor:
David A. Reardon, Patrick Y. Wen, Rakesh K. Jain, Alona Muzikansky, Dan G. Duda, Wendy M. Blumenschein, Qing Zhao, Jennifer H. Yearley, Mariano Severgnini, David J. Cote, Timothy R. Smith, Sarah Gaffey, Christine McCluskey, Howard Colman, Thomas Kaley, Leia Nghiemphu, John de Groot, Justin T. Jordan, Jennifer L. Clarke, Katherine Peters, Annette M. Molinaro, Lakshmi Nayak
Supplemental Text
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff0627cda1dff7ebc13ce169bcbb198
https://doi.org/10.1158/1078-0432.22479272.v1
https://doi.org/10.1158/1078-0432.22479272.v1
Autor:
David A. Reardon, Thomas Kaley, Raymond Y. Huang, Todd Creasy, Nicholas M. Durham, Melissa de los Reyes, Ralph Venhaus, Paul Schwarzenberger, Aileen Ryan, Toni Ricciardi, Andrew J. Park, Mary Macri, Patrick Y. Wen, Christina Holcroft, Julia Hayden, Sarah Gaffey, Elizabeth George, Elizabeth Flagg, Hui K. Gan, Timothy Cloughesy, Michael Lim, Gavin P. Dunn, Jennifer L. Clarke, Jorg Dietrich, Nathan Standifer, Lakshmi Nayak
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014926235dac95b0f63a0865ce8d1cc5
https://doi.org/10.1158/1078-0432.22486830
https://doi.org/10.1158/1078-0432.22486830